Vaccination of infants with a four-dose and a three-dose vaccination schedule

Vaccine

Volumn 18, Issue 9-10, 1999, Pages 884-891

  Taranger, John ^a   Trollfors, Birger ^a   Knutsson, Nina ^a   Sundh, Valter ^a   Lagergård, Teresa ^b   Østergaard, Erik ^c  

^a Goteborg Pertussis Vaccine Trial   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Antibodies; Infants; Vaccine

Indexed keywords

ANTIBODY; ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; EDEMA; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN MANIFESTATION; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; POLIOVIRUS VACCINE, INACTIVATED; SWEDEN; VACCINES, CONJUGATE;

EID: 0032747393     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00341-2     Document Type: Article

References (26)

1. American Academy of Pediatrics. Active and Passive Immunization. In: Peter G, editor. 1997 Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:1-71.
2. Helwig H., Mertsola J., Harvey D., Nicolopoulos D., Schaack J.C., Sedlak W. Childhood immunisation in the European Union. Eur. J. Pediatr. 157:1998;676-680.
3. Trollfors B., Taranger J., Lagergård T., Lind L., Sundh V., Zackrisson G., Lowe C.U., Blackwelder W., Robbins J.B. A placebo-controlled trial of a pertussis toxoid vaccine. N. Engl. J. Med. 333:1995;1045-1050.
4. Taranger J, Trollfors B, Lagergård T. Clinical trials of a monocomponent pertussis toxoid vaccine (NICHD-Ptxd) - a technical report. Göteborg University, Göteborg, Sweden. Graphic Systems AB, 1995.
5. Claesson B.A., Trollfors B., Lagergård T., Taranger J., Bryla D., Otterman G., Cramton T., Yang Y., Reimer C.B., Robbins J.B., Schneerson R. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18 to 23 month old children. J. Pediatr. 112:1988;695-702.
6. Melnick J.L., Wenner H.A., Phillips C.A. Lennette E.H., Schmidt N.J. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. 1979;American Public Health Association, Inc, Washington, DC.
7. Cody C.L., Baraff L.J., Cherry J.D., Marcy S.M., Manclark C.R. Nature and rates of adverse reactions with DTP and DT immunizations in infants and children. Pediatrics. 68:1981;650-660.
8. Olin P., Rasmussen F., Gustafsson L., Hallander H.O., Heijbel H. Randomised controlled trial of two-component, three-component and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Lancet. 350:1997;1569-1577.
9. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:1996;349-355.
10. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A.E., Anemona A., Ciofi degli Atti M.L., Giammanco A., Panel P., Blackwelder W.C., Klein D.L., Wassilak S.G.F. A controlled trial of two acellular and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:1996;341-348.
11. Smith J.W.G. Diphtheria and tetanus toxoids. Brit. Med. Bull. 25:1969;177-182.
12. Granström M., Olinder-Nielsen A.M., Holmblad P., Mark A., Hanngren K. Specific immunoglobulin for treatment of whooping cough. Lancet. 338:1991;1230-1233.
13. Storsaeter J., Hallander H.O., Gustafsson L., Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 16:1998;1907-1916.
14. Cherry J.D., Gornbein J., Heininger U., Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine. 16:1998;1901-1906.
15. Robbins J.B., Parke J.C. Jr, Schneerson R., Whisnant J.K. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res. 7:1973;103-110.
16. Käyhty H., Peltola H., Karanko V., Mäkelä P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 147:1983;1100.
17. Sutter R.W., Pallansch M.A., Sawyer L.A., Cochi S.L., Hadler S.C. Defining surrogate serolgic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann. NY Acad. Sci. 754:1995;289-299.
18. Carlsson R.-M., Claesson B.A., Selstam U., Fagerlund E., Granström M., Blondeau C., Hoffenbach A. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age. Pediatr. Infect. Dis. J. 17:1998;1026-1033.
19. Fecsik A.I., Butler W.T., Coons A.H. Studies on antibody production. XI. Variation in the secondary response as a function of the length of the interval between the two antigenic stimuli. J. Exper. Med. 120:1964;1041-1049.
20. Blennow M., Granström M., Jäätmaa E., Olin P. Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial. Pediatrics. 82:1988;293-999.
21. Isacson J., Trollfors B., Taranger J., MacDowall I., Johansson J., Lagergård T., Robbins J.B. Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. Pediatr. Infect. Dis. J. 13:1994;22-27.
22. Schneerson R., Robbins J.B. Induction of serum Haemophilus influenzae type b capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5. New. Engl. J. Med. 292:1975;1093-1096.
23. Claesson B.A., Trollfors B., Anderson P.W., Johansson J., Taranger J., Schneerson R., Robbins J.B. Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J. 15:1996;170-172.
24. Böttiger, M. The elimination of polio in the Scandinavian countries. Public Health Rev. 1993-91, 21, 27-33.
25. Garpenholt Ö., Silfverdal S.-A., Hugosson S., Fredlund H., Bodin L., Romanus V., Olcén P. The impact of Haemophilus influenzae type b vaccination in Sweden. Scand. J. Infect. Dis. 28:1996;165-169.
26. Krantz I., Taranger J., Trollfors B. Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. Int. J. Epidemiol. 18:1989;959-963.